

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.631, 2011-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Docetaxel delivers over doxorubicin for early breast cancer
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :


By Escobar Pedro F Rose Peter G
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. :


Paclitaxel + carboplatin, docetaxel alone, for endometrial cancer
Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. :


Gemcitabine enhances carboplatin for recurrent ovarian cancer
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :


QOL better with carboplatin + paclitaxel for ovarian cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 498, 2006-01 ,pp. :